Morgan Stanley reiterated coverage on IsoPlexis with a new price target

2/15/22 10:15:01 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Morgan Stanley reiterated coverage of IsoPlexis with a rating of Overweight and set a new price target of $12.00 from $17.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ISO

Date	Price Target	Rating	Analyst
2/15/2022	$17.00 → $12.00	Overweight	Morgan Stanley
1/27/2022	$20.00 → $15.00	Outperform	SVB Leerink
11/19/2021	$24.00	Outperform	Evercore ISI Group
11/11/2021	$17.00 → $20.00	Outperform	SVB Leerink
11/2/2021	$17.00	Outperform	SVB Leerink
11/2/2021		Outperform	Cowen & Co.
11/2/2021	$16.00	Overweight	Morgan Stanley